Clinical features and treatment outcomes of patients with tearing after chemotherapy.
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
/ adverse effects
Dacryocystorhinostomy
Female
Follow-Up Studies
Humans
Interferometry
Intubation
/ methods
Lacrimal Duct Obstruction
/ chemically induced
Light
Lipid Metabolism
/ physiology
Male
Meibomian Gland Dysfunction
/ chemically induced
Middle Aged
Neoplasms
/ drug therapy
Retrospective Studies
Slit Lamp Microscopy
Suction
Tears
/ physiology
Treatment Outcome
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
14
12
2017
accepted:
04
10
2018
revised:
09
04
2018
pubmed:
12
12
2018
medline:
23
5
2020
entrez:
12
12
2018
Statut:
ppublish
Résumé
To evaluate the clinical features and treatment outcomes of patients complaining of tearing after receiving chemotherapy. The clinical records of patients who complained of tearing between August 2014 and February 2016, and underwent or were undergoing chemotherapy were retrospectively reviewed. Clinical measurements were as follows: LipiView This study included 34 eyes of 17 patients with a mean age of 62.4 ± 14.82 years. The mean follow-up period was 9.6 months. On syringing, 10 eyes (29.4%) showed total regurgitation, 19 eyes (55.9%) showed partial regurgitation, and 5 eyes (14.7%) showed no regurgitation. On LipiView Because of the high incidence of accompanying meibomian gland loss in cases of lacrimal drainage system (LDS) obstruction, reflex tearing by mebibomian gland dysfunction should also be considered for proper management of tearing. Early recognition and management of LDS stenosis could result in patients undergoing surgery with a lower burden.
Identifiants
pubmed: 30531801
doi: 10.1038/s41433-018-0305-y
pii: 10.1038/s41433-018-0305-y
pmc: PMC6707285
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
746-753Références
Cornea. 2014 May;33(5):448-52
pubmed: 24608255
Arch Ophthalmol. 1981 Feb;99(2):284-6
pubmed: 7469866
Ann Intern Med. 1978 May;88(5):657
pubmed: 646255
Cancer. 2003 Aug 1;98(3):504-7
pubmed: 12879466
Pharm Pract (Granada). 2006 Apr;4(2):55-9
pubmed: 25247000
Am J Ophthalmol. 1991 Nov 15;112(5):502-6
pubmed: 1951585
Ophthalmology. 2001 May;108(5):994-5
pubmed: 11320034
Acta Ophthalmol Scand. 2000 Feb;78(1):110-3
pubmed: 10726804
Surv Ophthalmol. 1989 Nov-Dec;34(3):209-30
pubmed: 2694416
Ophthalmic Plast Reconstr Surg. 2003 Jul;19(4):305-8
pubmed: 12878879
Ophthalmology. 2008 May;115(5):911-5
pubmed: 18452765
Doc Ophthalmol. 1995;90(1):1-6
pubmed: 8549238
Ophthalmic Plast Reconstr Surg. 2007 Mar-Apr;23(2):170-1
pubmed: 17413646
Ophthalmic Plast Reconstr Surg. 2017 Jan/Feb;33(1):9-12
pubmed: 27429222
BMC Cancer. 2015 Oct 24;15:796
pubmed: 26498928
Optom Vis Sci. 2012 May;89(5):788-94
pubmed: 22525129
Ophthalmic Surg Lasers. 1999 Feb;30(2):105-8
pubmed: 10037204
Surv Ophthalmol. 2006 Jan-Feb;51(1):19-40
pubmed: 16414359
Am J Ophthalmol. 2005 Aug;140(2):325-7
pubmed: 16086962
Eye Contact Lens. 2003 Apr;29(2):96-9
pubmed: 12695712
Cornea. 2017 May;36(5):572-577
pubmed: 28257384
Ophthalmic Plast Reconstr Surg. 2003 May;19(3):216-24
pubmed: 12918558
J Clin Oncol. 2006 Aug 1;24(22):3619-22
pubmed: 16877729